Revi implantable tibial neuromodulation demonstrated durable efficacy, high patient satisfaction, and an excellent safety profile through 3 years in women with UUI.
Does the Revi implantable tibial neuromodulation system provide durable efficacy and safety in women with UUI?
The Revi implantable tibial neuromodulation system demonstrates durable efficacy, high satisfaction, and safety over 3 years in women with urge urinary incontinence.
Tasa de eventos absoluta: 0% vs 0%
In women with UUI, Revi - an iTNM system powered by a patient-controlled, external wearable ankle device - showed meaningful and durable efficacy, high patient satisfaction, and an excellent safety profile through 3 years.
“With the most comprehensive and longest-term data in Implantable Tibial Neuromodulation, BlueWind has set a new benchmark for durable, patient-centered therapy for UUI. Revi delivers consistent, long-lasting outcomes, proving that effective, minimally invasive treatment can be both simple and transformative. These results reinforce Revi's position as the gold standard for clinical evidence, patient satisfaction, and sustained quality-of-life improvement in urgency urinary incontinence.”
Amundsen et al. (Mon,) reported a other. Revi implantable tibial neuromodulation demonstrated durable efficacy, high patient satisfaction, and an excellent safety profile through 3 years in women with UUI.